Growth Axis and Syndromes

ea0110ep719 | Growth Axis and Syndromes

The effects of long-acting pegylated recombinant human growth hormone (jintrolong) on body composition and bone mass in transitional growth hormone deficiency

ea0110ep720 | Growth Axis and Syndromes

Overgrowth: one patient, two syndromes

ea0110ep721 | Growth Axis and Syndromes

Clinical and genetic characteristics of cornelia de lange syndrome: a retrospective study of 20 pediatric patients in China

ea0110ep722 | Growth Axis and Syndromes

Development of AI-based growth prediction models for children with growth disorders: a 3-year analysis using the lg growth study

ea0110ep723 | Growth Axis and Syndromes

The molar ratio of IGF-1/IGFBP-3 serves as a biomarker for evaluating the therapeutic efficacy of recombinant human growth hormone

ea0110ep724 | Growth Axis and Syndromes

Growth hormone testing in prader willi syndrome: our experience with glucagon test

ea0110ep728 | Growth Axis and Syndromes

Disease activity drop-off in elderly patients with active acromegaly over a median follow-up period of ten years: a longitudinal, restrospective study

ea0110ep729 | Growth Axis and Syndromes

Clinical heterogeneity of sanjad sakati syndrome: experience from a single tertiary center in kuwait

ea0110ep730 | Growth Axis and Syndromes

Short stature in CHARGE syndrome

ea0110ep731 | Growth Axis and Syndromes

q26.3 Deletion effect on growth: a case report

ea0110ep732 | Growth Axis and Syndromes

Is L-dopa test effective in detecting adrenal insufficiency with preliminary diagnosis of growth hormone deficiency in children with short stature?

ea0110ep733 | Growth Axis and Syndromes

Treatment responce of the growth hormone in 3M syndrome: a single center experience

ea0110ep734 | Growth Axis and Syndromes

"A shared GHSR gene variant in children with short stature and growth hormone deficiency: potential clinical relevance"

ea0110ep735 | Growth Axis and Syndromes

Development of a minimum dataset (MDS) for the monitoring of growth hormone therapy in children with prader willi syndrome (PWS) - a globe-reg initiative

ea0110ep736 | Growth Axis and Syndromes

Three decades of growth hormone therapy in prader-willi syndrome: insights from belgium

ea0110ep737 | Growth Axis and Syndromes

New evidence of growth hormone treatment benefit on bone mineralization during transition from paediatric to adult care in a growth hormone deficient french cohort

ea0110ep738 | Growth Axis and Syndromes

Insulin tolerance test for the diagnosis of adult GH deficiency: definition of BMI-dependent cut-offs using a clinical gold standard

ea0110ep739 | Growth Axis and Syndromes

GLP-1 receptor agonists as therapeutic approach to severe obesity in PHP/iPPSD: two case reports

ea0110ep740 | Growth Axis and Syndromes

The effects of long-acting growth hormone therapy on serum GH and IGF-i levels and potential safety risks compared to physiological pulsatile growth hormone and daily gh injections

ea0110ep741 | Growth Axis and Syndromes

Positive impact of healthcare professionals’ interaction with a digital health platform on patient adherence to recombinant human growth hormone therapy

ea0110ep742 | Growth Axis and Syndromes

Results of treatment with recombinant human growth hormone (rhGH) in patients with noonan syndrome. albanian experience

ea0110ep743 | Growth Axis and Syndromes

Growh patterns and genotype-phenotype correlations in tricho-rhino-phalangeal syndrome type i: insights from a korean cohort

ea0110ep744 | Growth Axis and Syndromes

Noonan syndrome: a retrospective observational study from a paediatric endocrinology unit at a portuguese tertiary hospital

ea0110ep745 | Growth Axis and Syndromes

An atypical case of silver-russel syndrome linked to a novel variant in HMGA2 gene

ea0110ep746 | Growth Axis and Syndromes

A single center real world experience with vosoritide for the treatment of children with achondroplasia

ea0110ep747 | Growth Axis and Syndromes

Sex steroid priming prior to growth hormone stimulation testing in peripubertal adolescents with short stature?

ea0110ep748 | Growth Axis and Syndromes

Lamb-Shaffer syndrome as a rare cause of short stature

ea0110ep749 | Growth Axis and Syndromes

Identification of a novel heterozygous variant of the aggrecan gene in a family with idiopathic short stature and accelerated bone maturation: treatments and challenges

ea0110ep750 | Growth Axis and Syndromes

Differences in age at treatment start of recombinant human growth hormone therapy among european countries

ea0110ep751 | Growth Axis and Syndromes

(Un)satisfactory effectiveness of whole-exome sequencing in detecting genetic causes of differential sexual development in 46,XY patients

ea0110ep752 | Growth Axis and Syndromes

Mixed segmental uniparental disomy of chromosome 15q11-q1 coexists with homozygous variant in GNB5 gene in child with Prader-Willi and Lodder-Merla syndrome

ea0110ep753 | Growth Axis and Syndromes

The impact of growth hormone treatment on physical performance in adult patients with severe growth hormone deficiency - preliminary results

ea0110ep754 | Growth Axis and Syndromes

Severe growth hormone deficiency in siblings: a case study of GH1-related IGHD in a consanguineous family

ea0110ep755 | Growth Axis and Syndromes

Integrating patient-generated health data into growth hormone therapy: perspectives from the paediatric endocrinologists in the gulf cooperation council

ea0110ep756 | Growth Axis and Syndromes

Self-resolving regional lipodystrophy secondary to somatrogon therapy: a case report

ea0110ep757 | Growth Axis and Syndromes

Filippi syndrome – a rare syndrome as a cause of short stature and primary amenorrhea

ea0110ep758 | Growth Axis and Syndromes

Survey of electronic growth chart use reveals inconsistent provision and awareness of functionality across the United Kingdom

ea0110ep759 | Growth Axis and Syndromes

Real world data for the first year of treatment with somatrogon of children and adolescents with growth hormone deficiency (GHD)

ea0110ep760 | Growth Axis and Syndromes

Growth hormone treatment response in patients with biologically inactive growth hormone

ea0110ep761 | Growth Axis and Syndromes

Intellectual and developmental function in children with Silver-Russell syndrome

ea0110ep762 | Growth Axis and Syndromes

Patient dynamics and real-world insights from a somatropin patient support program (PSP): outcomes from 24,000 treated patients in brazil

ea0110ep763 | Growth Axis and Syndromes

Adherence and its key-driving factors to growth hormone treatment in children with growth disorders: the french SCOPE study

ea0110ep764 | Growth Axis and Syndromes

Paradoxical growth in multiple pituitary deficiencies: two clinical cases of obese pediatric patients

ea0110ep765 | Growth Axis and Syndromes

Growth hormone insensitivity in an infant with LZTR1 mutation and growth failure: a case report

ea0110ep766 | Growth Axis and Syndromes

Autosomal recessive ovarian dysgenesis associated to gh-deficiency and pituitary hyperplasia: a case report

ea0110ep767 | Growth Axis and Syndromes

Experience with vosoritide for achondroplasia: insights from Kazakhstan

ea0110ep768 | Growth Axis and Syndromes

Optimizing therapies for advanced bone age in obesity-related short stature, cah, precocious puberty, and sga: an updated view

ea0110ep769 | Growth Axis and Syndromes

A rare cause of short stature: a case with a TBX6 gene variant

ea0110ep770 | Growth Axis and Syndromes

A rare disease presented with bow legs

ea0110ep771 | Growth Axis and Syndromes

A case of spondyloepiphyseal dysplasia, kimberley type, caused by a novel variant in the ACAN gene

ea0110ep772 | Growth Axis and Syndromes

Evaluation of factors that predict a good response to growth hormone treatment in patients with isolated growth hormone deficiency in first year of therapy - single centre study

ea0110ep773 | Growth Axis and Syndromes

Mauriac syndrome in a teenager with dual autoimmune disorders: a case report

ea0110ep774 | Growth Axis and Syndromes

Effects of growth hormone therapy in patients with prader-willi syndrome: the first algerian experience

ea0110ep775 | Growth Axis and Syndromes

The rare co-occurence of pituitary gigantism and thrombocytopenia!

ea0110ep776 | Growth Axis and Syndromes

Response to recombinant growth hormone therapy in an indian girl with 3-M syndrome

ea0110ep777 | Growth Axis and Syndromes

A paediatric case of progeroid lipodystrophy due to a de novo mutation in POLD1 gene

ea0110ep778 | Growth Axis and Syndromes

Case series on growth hormone deficiency: clinical and endocrinological insights

ea0110ep779 | Growth Axis and Syndromes

SEENEZ trial: growth prediction model from mid-puberty to near-adult height in adolescents with idiopathic isolated growth hormone deficiency treated with growth hormone

ea0110ep780 | Growth Axis and Syndromes

Short stature in short bowel syndrome: complex interplay between nutrition and growth

ea0110ep781 | Growth Axis and Syndromes

Comorbidities in pediatric turner syndrome: differences between 45,X0 and mosaic karyotypes

ea0110ep782 | Growth Axis and Syndromes

Insights from IGF-1 generation test responses in growth disorders

ea0110ep783 | Growth Axis and Syndromes

Growth and pubertal outcomes in CHARGE syndrome: a case study of hormone replacement therapy

ea0110ep784 | Growth Axis and Syndromes

Our experience with somatrogon: therapeutic efficacy, adult height, safety and adherence

ea0110ep785 | Growth Axis and Syndromes

A post market observational study to evaluate user’s perception on technology acceptance and usability of two generations of digital devices to manage growth disorders across france and spain

ea0110ep786 | Growth Axis and Syndromes

Neurofibromatosis type 1 revealed through growth delay: a case report

ea0110ep787 | Growth Axis and Syndromes

Short stature due to ADAMTSL2 variant as a rare cause of geleophysic dysplasia: growth hormone had no role in treatment

ea0110ep788 | Growth Axis and Syndromes

Access to growth hormone treatment for short stature children with noonan syndrome-the experience of the Wroclaw centre, poland

ea0110ep789 | Growth Axis and Syndromes

Use of CGMS to identify early glucose changes in patients on growth hormone therapy

ea0110ep790 | Growth Axis and Syndromes

Growth hormone therapy in montenegro over two decades

ea0110ep791 | Growth Axis and Syndromes

An atypical case of a patient with prader-willi syndrome- difficult diagnostic pathway

ea0110ep792 | Growth Axis and Syndromes

Bridging the treatment gap: growth hormone therapy for noonan syndrome in portugal

ea0110ep793 | Growth Axis and Syndromes

Genotype-phenotype correlation of endocrine comorbidities in turner syndrome

ea0110ep794 | Growth Axis and Syndromes

Role of molecular investigation for diagnosing short stature: a case report of a variant in the COL9A3 and UBA5 genes

ea0110ep795 | Growth Axis and Syndromes

Growth hormone treatment in children with growth hormone deficiency: searching for predictors affecting adult height

ea0110ep796 | Growth Axis and Syndromes

Enhancing paediatric care: insights from healthcare professionals on the quality and usability of digital devices in a participatory workshop in Korea

ea0110ep797 | Growth Axis and Syndromes

Efficacy and safety of three-years growth hormone treatment in girls with turner syndrome and growth hormone deficiency: a case-control study

ea0110ep798 | Growth Axis and Syndromes

Juberg-Marsidi syndrome coexisting with multihormonal hypopituitarism - a case report

ea0110ep799 | Growth Axis and Syndromes

Circulating IGF-1 levels and trends in response to daily and weekly gh therapies: a comparative analysis

ea0110ep800 | Growth Axis and Syndromes

Myhre syndrome – it is never too late

ea0110ep801 | Growth Axis and Syndromes

Short stature and treatment in KBG syndrome: a case report

ea0110ep802 | Growth Axis and Syndromes

Serum levels of intact and total IGFBP-4, and stanniocalcin-2 in congenital isolated gh deficiency

ea0110ep803 | Growth Axis and Syndromes

The significance of cardiac MRI in transition care for Turner Syndrome: a prospective study

ea0110ep804 | Growth Axis and Syndromes

Effects of gonadotropin-releasing hormone analog, alone and in combination with recombinant human growth hormone, on height in girls with early puberty across age groups

ea0110ep805 | Growth Axis and Syndromes

ZTTK syndrome with growth hormone deficiency: a case report and literature review

ea0110ep806 | Growth Axis and Syndromes

Whole exome sequencing uncovers the genetic diagnoses and new candidate genes for growth disorders in a cohort from the brazilian amazon

ea0110ep807 | Growth Axis and Syndromes

Rare TXNRD2-related familial glucocorticoid deficiency in a chinese patient: a case report

ea0110ep808 | Growth Axis and Syndromes

GH therapy and its short-term effectiveness in hong kong (the growth study)

ea0110ep809 | Growth Axis and Syndromes

Identification of a novel IGF1R mutation in a family with short stature: a case report

ea0110ep810 | Growth Axis and Syndromes

The impact of puberty on IGF-1: factors influencing growth and development

ea0110ep811 | Growth Axis and Syndromes

Safety profile of large IGF-1 fluctuations: long-acting growth hormone therapy vs. daily growth hormone therapy

ea0110ep812 | Growth Axis and Syndromes

Diagnostic utility of IGF-1 levels in growth and puberty-related disorders: a comprehensive review

ea0110ep813 | Growth Axis and Syndromes

Are children with atopic eczema at higher risk of poor linear growth? - A systematic review of the literature

ea0110ep814 | Growth Axis and Syndromes

Clinical features and genetic analysis of an SGA-born patient with IGF1R heterozygous mutation

ea0110ep815 | Growth Axis and Syndromes

Experience with growth hormone therapy in a rare skeletal dysplasia

ea0110ep816 | Growth Axis and Syndromes

Experience after 30 years of acromegaly management at the hospital clínico universitario de valladolid

ea0110ep817 | Growth Axis and Syndromes

Cranio-lenticulo-sutural dysplasia (CLSD) as a rare cause of syndromic short stature: a case report of a complex clinical presentation

ea0110ep818 | Growth Axis and Syndromes

Differences in treatment efficacy between idiopathic short stature and other conditions with advanced bone age

ea0110ep819 | Growth Axis and Syndromes

INSIGHTS-GHT: first evaluation of paediatric patients with long-acting growth hormone therapy (LAGH) from the german registry

ea0110ep820 | Growth Axis and Syndromes

Clinical and biochemical variation in a consanguineous family with heterozygous MAP2K2 variant and hetero/homozygous TSH receptor variant

ea0110ep821 | Growth Axis and Syndromes

Prader-willi syndrome: a journey of resilience againt hyperphagia and developmental challenges

ea0110ep822 | Growth Axis and Syndromes

Childhood growth hormone deficiency and continuation of therapy in adulthood: case series of patients followed at a tertiary center

ea0110ep823 | Growth Axis and Syndromes

Noonan syndrome and growth delay: the hope of optimized growth with growth hormone therapy

ea0110ep824 | Growth Axis and Syndromes

Skeletal ciliopathy and short rib dysplasia: a case report with response to growth hormone therapy

ea0110ep825 | Growth Axis and Syndromes

A rare cause of short stature: cases with heterozygous mutations in the PCNT gene

ea0110ep826 | Growth Axis and Syndromes

Beckwith wiedemann syndrome associated with transient typical features of classical congenital adrenal hyperplasia: a case report

ea0110ep827 | Growth Axis and Syndromes

Differences in age, gender, and hormonal immunohistochemical profiles among patients with acromegaly and non-functioning pituitary adenomas

ea0110ep828 | Growth Axis and Syndromes

Socio-demographic profile in adult patients with turner syndrome

ea0110ep829 | Growth Axis and Syndromes

GH therapy in patients with empty sella syndrome and growth hormone deficiency: two cases with transition to weekly treatment

ea0110ep830 | Growth Axis and Syndromes

Evaluating the IGF-1 generation test as a predictor of growth outcomes across pediatric growth disorders"

ea0110ep831 | Growth Axis and Syndromes

A novel IGF1R variant in a patient with short stature in qatar

ea0110ep832 | Growth Axis and Syndromes

Effect of urea ingestion on growth hormone levels in healthy adults – An analysis of a double-blind, randomized, placebo-controlled cross-over trial

ea0110ep833 | Growth Axis and Syndromes

An early diagnosed leri-weill dyschondrosteosis case caused by unusual genetic results

ea0110ep834 | Growth Axis and Syndromes

The clinical and mutational spectrum of ulnar-mammary syndrome: two case reports and literature review

ea0110ep835 | Growth Axis and Syndromes

Empty sella syndrome and growth hormone deficiency in a 6-year-old boy with short stature

ea0110ep836 | Growth Axis and Syndromes

A clinical case of rasopathies caused by a mutation in the SHOC2 gene

ea0110ep837 | Growth Axis and Syndromes

Pharmacological treatment of growth in boys with delayed or slow progression of puberty

ea0110ep838 | Growth Axis and Syndromes

Spontaneous pregnancy in a patient with turner syndrome

ea0110ep839 | Growth Axis and Syndromes

Shaff yang syndrome and growth hormone therapy

ea0110ep840 | Growth Axis and Syndromes

Design of a randomized, multicentre, phase 2 study of vosoritide in children with turner syndrome, noonan syndrome, or short stature homeobox-containing gene (SHOX) deficiency

ea0110ep841 | Growth Axis and Syndromes

Youn adults with prader willi syndrome - chalenge for endocrinologist, single centre observation

ea0110ep842 | Growth Axis and Syndromes

Paediatric langerhans cell histiocytosis disease: long-term sequelae in the hypothalamic endocrine system

ea0110ep843 | Growth Axis and Syndromes

Statural advance: a challenge for diagnosis and management

ea0110ep844 | Growth Axis and Syndromes

Clinical and genetic analysis of three cases of short stature caused by the GHSR gene mutation in chinese

ea0110ep845 | Growth Axis and Syndromes

Endocrine comorbidities in adult patients with Turner syndrome

ea0110ep846 | Growth Axis and Syndromes

Somatotroph non functionnal pituitary adenoma: a case report

ea0110ep847 | Growth Axis and Syndromes

A new prospective for the growth suppression in children with profound mental disability; case report and ethical consideration

ea0110ep848 | Growth Axis and Syndromes

Glucose metabolism disorders in patients with acromegaly

ea0110ep849 | Growth Axis and Syndromes

Pituitary acrogigantism from diagnosis to effective treatment- case study

ea0110ep850 | Growth Axis and Syndromes

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

BiosciAbstracts